AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2020
Dec 11, 2020
33298_dirs_2020-12-11_df77aa49-1e6e-4dbb-8658-a4f755391bb3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2020-12-08
Reporting Person: Alvarez Nicholas P (Chief Acquisition Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-08 | Options to purchase Common Stock | $7.92 | A | 200000 | Acquired | Common Stock, par value $0.001 (200000) | Direct |
Footnotes
F1: The Options were issued to Mr. Alvarez pursuant to the terms of an amended and restated employment agreement, dated December 8, 2020 (the "Effective Date"), by and between Mr. Alvarez and the Issuer. The options shall vest at a rate of 5,555 options each month for thirty-five (35) consecutive months beginning on the Effective Date, with the final 5,575 shares vesting on December 8, 2023.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17